Kapil Sharma’s Weight Loss Journey: The 21-21-21 Rule Behind the Transformation

Kapil Sharma has recently turned heads with his impressive weight-loss transformation, as seen on the latest season of The Great Indian Kapil Show on Netflix. While fans were quick to notice his slimmer, healthier appearance, the credit behind this transformation goes to celebrity fitness coach Yogesh Bhateja, known for training the likes of Sonu Sood and Farah Khan. A Mindful Approach to Fitness In an interview on the YouTube channel GunjanShouts (April 6), Bhateja broke down the philosophy and practical steps behind Kapil’s journey. According to the trainer, transformation begins not in the gym but in the mindset. Most people, he noted, don’t think about fitness until health issues arise — and they often underestimate the impact of basic lifestyle changes. Bhateja emphasized the importance of awareness, saying that small decisions — like monitoring water intake, breathing, sleep, and food habits — lay the foundation for bigger results. Kapil Sharma’s transformation, he said, began with these small but crucial changes. No Crash Diets, No Burnouts Yogesh deliberately avoided pushing Kapil into intense workouts or restrictive diets. Instead, he ensured sustainable progress by listening to Kapil’s body. On days when the comedian wanted to slow down, Bhateja encouraged him to do stretches instead of high-impact routines. This helped Kapil stay consistent without feeling overwhelmed. The 21-21-21 Rule Explained At the heart of Kapil’s weight loss was Bhateja’s simple but powerful method — the 21-21-21 rule. This three-phase routine spans 63 days and focuses on building discipline gradually: Phase 1 – First 21 Days: Movement “Move your body for 21 days. Don’t worry about food yet. Eat jalebis if you like, but just start moving,” Bhateja said. Phase 2 – Next 21 Days: Diet Modification Phase 3 – Final 21 Days: Emotional Detox Why This Method Works According to Bhateja, this 63-day cycle helps people develop an attitude toward fitness without pain or pressure. By focusing on one element at a time, beginners are more likely to stick with it. “Once you complete this process, you’ll start going to the gym willingly on the 64th day. You won’t need motivation — because now the body and mind are aligned,” he explained. He also pointed out that by the 42nd day, visible results start to show, which increases one’s motivation to push further. The key, he stressed, is gradual change over forceful transformation. Final Takeaway Kapil Sharma’s transformation isn’t just about looking better — it’s a lesson in sustainable, holistic wellness. Through mindful habits, slow progression, and the 21-21-21 rule, the comedian found a way to get healthier without extreme diets or punishing workouts. Yogesh Bhateja’s method serves as a motivational blueprint for anyone looking to start their fitness journey — one day, one step at a time.

Puducherry’s TB Lab Ranked No. 1 Nationally, Leads in Advanced Testing and Early Detection

Puducherry’s Intermediate Reference Laboratory (IRL) at the Government Hospital for Chest Diseases has been ranked the best-performing TB laboratory in India, lauded for its exceptional diagnostic capacity and expansive reach beyond the Union Territory into Tamil Nadu and neighboring regions, according to S. Govindarajan, Mission Director of the Puducherry State Health Society (PSHS). The lab, a vital component of the National TB Elimination Programme (NTEP), conducts up to 1.2 lakh tests annually, supporting the detection and management of tuberculosis cases at the regional level. IRLs function as state-level hubs, linking peripheral labs with national reference centres through advanced testing and quality control. “We’ve seen a significant increase in our TB testing rate to 5,268 per lakh population in the first quarter of 2025 — a 136% jump compared to 2015,” Govindarajan said. High Testing Rates, Despite TB Deaths Though Puducherry faces a TB death rate of nearly 10% — largely due to patients from neighboring states seeking care — the territory has shown marked improvement in screening. The rate of examining presumptive TB cases increased from 2,233 per lakh in 2015 to 2,526 per lakh in 2024. “Presumptive TB” refers to individuals showing symptoms suggestive of the disease who require further testing for confirmation. Targeted, Community-Focused Interventions To combat community transmission, Puducherry has implemented door-to-door active case finding, focusing especially on vulnerable groups that may not present typical symptoms. In 2023, over 5.2 lakh individuals were screened, with more than 42,000 examined using ultraportable hand-held chest X-ray devices, said Dr. C. Venkatesh, State TB Officer. Abnormal findings were followed by NAAT (Nucleic Acid Amplification Test)—the gold standard for TB diagnosis. Further, under the national TB elimination program, 3.74 lakh vulnerable individuals were mapped and 3.8 lakh screened, achieving 102% coverage of the intended target. “This targeted approach is a game changer in early diagnosis and significantly boosts Puducherry’s potential to meet TB elimination goals,” said Dr. Venkatesh. A National Context India has achieved a 17.7% decline in TB incidence between 2015 and 2023, but the absolute number of cases remains high. The Union Health Ministry credits the improvement to advanced diagnostics, stronger policies, public-private partnerships, and a patient-first strategy. Puducherry’s success, especially with early detection using modern tools and strategic mapping of high-risk groups, is emerging as a model for other regions in the fight against tuberculosis.

Nixol 2025 Review: A Critical Look at the UK’s New Vegan Weight Loss Supplement

In 2025, Nixol, a plant-based, vegan-friendly dietary supplement, launched in the UK and Ireland with bold claims of supporting healthy weight management, boosting metabolism, and curbing cravings—without relying on synthetic stimulants or crash diets. Touted as a clean-label, natural solution for the modern wellness market, Nixol enters a crowded space with a unique multi-ingredient formula and a wellness-first philosophy. But how effective is it, really? 🔍 What Is Nixol? Nixol is designed for individuals struggling with: It claims to address these issues holistically using a mix of plant extracts, amino acids, essential minerals, and prebiotic fibers. Unlike fad diets or stimulant-heavy pills, Nixol promises sustainable results by promoting thermogenesis, enhancing digestion, stabilizing blood sugar, and supporting metabolic balance. 🌿 Key Ingredients: Are They Backed by Science? Nixol includes seven main ingredients, but critical analysis shows dosage may be too low to replicate clinical effects: Ingredient Role Clinical Dose vs. Nixol Dose Apple Cider Vinegar (100 mg) Appetite regulation, fat burning Clinical: 750–1500 mg; Nixol: 100 mg Guarana (100 mg) Thermogenesis, alertness Effective but limited human data Inulin (100 mg) Satiety, gut health Clinical: 21g/day; Nixol: 0.1g L-Glutamine (50 mg) Gut and muscle support Clinical: 35–40g/day; Nixol: 50 mg L-Leucine (unspecified) Muscle preservation Helpful, but unclear dose Zinc (14 mg) Metabolism, appetite At 140% NRV – clinically useful Chromium (40 µg) Blood sugar control, cravings Meets EU NRV standards 🧪 Verdict on Formula: While ingredients are well-researched, Nixol contains much lower doses than those shown to be effective in clinical studies. This means any benefits may be subtle or dependent on long-term use combined with lifestyle changes. ⚙️ How Does Nixol Claim to Work? Nixol targets four main areas of wellness: However, there’s no clinical data on Nixol’s full formulation, so results rely on the performance of individual ingredients—many of which are under-dosed. 🌍 Why the UK and Ireland? Nixol’s launch in the UK and Ireland was strategically timed, given rising obesity rates and growing demand for natural, vegan supplements. With over 25.9% of UK adults obese as of 2023 (Public Health England), Nixol taps into the clean-label movement—offering: This positions it well in a market increasingly skeptical of synthetic or exaggerated wellness claims. 📢 Customer Feedback & Industry Response Although early adopters appreciate its clean formulation, ease of use, and lack of side effects, many report that results are gradual rather than dramatic. Some highlight improved digestion and energy, but weight loss outcomes vary, especially without concurrent lifestyle adjustments. Fitness experts have noted the shortcomings in clinical dosing, while nutritionists point out that Nixol may work better as a wellness support supplement rather than a standalone weight-loss solution. ✅ Pros and ❌ Cons Pros: Cons: 🧠 Final Verdict: Is Nixol Worth It? Nixol has potential—but with caveats. Its natural approach, clean formulation, and appeal to conscious consumers are commendable. However, its low ingredient doses and lack of clinical trials suggest that it may be better suited for gentle metabolic support rather than aggressive fat loss. 💡 If you’re looking for a plant-based, stimulant-free aid to complement a healthy lifestyle, Nixol might be a low-risk, high-integrity option. But for rapid results or clinical-grade fat loss, it may fall short.

कोविड वैक्सीन और अचानक मौतों के बीच कोई संबंध नहीं: स्वास्थ्य मंत्रालय ने स्पष्ट किया

केंद्रीय स्वास्थ्य और परिवार कल्याण मंत्रालय ने आज स्पष्ट रूप से कहा कि देश के शीर्ष चिकित्सा अनुसंधान संस्थानों द्वारा की गई गहन जांच में कोविड-19 वैक्सीन और हाल में हुई अचानक वयस्क मौतों, विशेष रूप से हार्ट अटैक से हुई मौतों के बीच कोई संबंध नहीं पाया गया है। यह बयान भारतीय आयुर्विज्ञान अनुसंधान परिषद (ICMR) और अखिल भारतीय आयुर्विज्ञान संस्थान (AIIMS) द्वारा किए गए व्यापक अध्ययन के बाद आया है, जिसमें कोविड के बाद हुई अचानक मौतों की जांच की गई थी। स्वास्थ्य मंत्रालय की ओर से बुधवार को जारी प्रेस विज्ञप्ति में कहा गया,“ICMR और AIIMS द्वारा किए गए विस्तृत अध्ययन यह स्पष्ट रूप से सिद्ध करते हैं कि अचानक मौतों और कोविड-19 वैक्सीन के बीच कोई संबंध नहीं है।”विज्ञप्ति में आगे कहा गया कि, “ICMR और राष्ट्रीय रोग नियंत्रण केंद्र (NCDC) के अध्ययन यह लगातार प्रमाणित करते हैं कि कोविड वैक्सीन सुरक्षित और प्रभावी हैं, और गंभीर प्रतिकूल प्रभाव अत्यंत दुर्लभ हैं।” इन अनुसंधानों में पाया गया है कि जीवनशैली विकल्प, आनुवंशिक प्रवृत्ति और पहले से मौजूद बीमारियां अचानक मौतों के प्रमुख कारण हैं। हालांकि हार्ट अटैक वयस्कों में अचानक मृत्यु का मुख्य कारण बना हुआ है, लेकिन प्रारंभिक विश्लेषण दर्शाता है कि मौतों के कारणों में पिछले वर्षों की तुलना में कोई बड़ा बदलाव नहीं आया है। यह सरकारी घोषणा वैक्सीन को लेकर फैले भ्रम और गलत सूचनाओं को दूर करने का प्रयास है, ताकि लोगों का टीकाकरण कार्यक्रम में भरोसा फिर से बहाल हो सके।

मध्यप्रदेश में जल जीवन मिशन घोटाले को लेकर राजनीतिक तूफान, कांग्रेस ने मांगा मंत्री सम्पतिया उइके का इस्तीफा

मध्यप्रदेश की राजनीति में एक बार फिर भ्रष्टाचार के आरोपों ने हलचल मचा दी है। राज्य की जन स्वास्थ्य यांत्रिकी मंत्री सम्पतिया उइके पर जल जीवन मिशन में ₹1000 करोड़ की रिश्वत से जुड़ा गंभीर आरोप लगा है। इन आरोपों को सबसे पहले पूर्व विधायक किशोर समरीते ने उठाया, जिसके बाद जन स्वास्थ्य यांत्रिकी विभाग ने आंतरिक जांच शुरू कर दी है। कांग्रेस का हमला और इस्तीफे की मांग राज्य कांग्रेस अध्यक्ष जीतू पटवारी ने इन आरोपों को आधार बनाते हुए मंत्री सम्पतिया उइके से इस्तीफे की मांग की है। पटवारी ने चुनौती दी है कि सरकार साबित करे कि जल जीवन मिशन की 10% से अधिक परियोजनाएं पूर्ण हुई हैं। उन्होंने यह भी कहा कि वे प्रधानमंत्री नरेंद्र मोदी से भौतिक सत्यापन की मांग करेंगे ताकि हकीकत सामने आ सके। उन्होंने सोशल मीडिया पर भी सरकार पर निशाना साधते हुए लिखा है कि यह घोटाला राज्य सरकार में व्यापक भ्रष्टाचार की बानगी है। मंत्री का इनकार और सरकार का समर्थन मंत्री सम्पतिया उइके ने इन आरोपों से साफ इनकार किया है। उन्होंने अपने आदिवासी पृष्ठभूमि और सेवा भावना को सामने रखते हुए कहा कि यह आरोप राजनीतिक साजिश हैं। वहीं मुख्यमंत्री मोहन यादव से उन्होंने समर्थन मांगा है, जिनके जल्द इस मुद्दे पर बयान देने की उम्मीद है। उप मुख्यमंत्री राजेंद्र शुक्ला ने भी मंत्री का बचाव करते हुए कहा कि आरोप लगाने वाले की विश्वसनीयता संदिग्ध है और यह सिर्फ कांग्रेस की राजनीतिक चाल है। सियासी तापमान और जांच की दिशा जैसे-जैसे जांच आगे बढ़ेगी, राजनीतिक टकराव और तेज़ होने की संभावना है। कांग्रेस इसे व्यवस्थागत भ्रष्टाचार का प्रतीक मान रही है, वहीं बीजेपी सरकार इसे विपक्ष का दुष्प्रचार बता रही है। अब सबकी निगाहें जांच के नतीजों और केंद्र सरकार की प्रतिक्रिया पर टिकी हैं, जो इस सियासी ड्रामे का अगला अध्याय तय करेंगे।

Trump’s Foreign Aid Cuts Could Lead to 14 Million Deaths by 2030, Warns The Lancet

A new study published in The Lancet medical journal has issued a stark warning: U.S. President Donald Trump’s sweeping cuts to foreign humanitarian aid could result in over 14 million additional deaths by 2030, including 4.5 million children under five. The findings come amid global concern over the Trump administration’s decision to cancel more than 80% of programmes run by the U.S. Agency for International Development (USAID). U.S. Secretary of State Marco Rubio confirmed the move in March, part of a broader cost-cutting initiative supported by billionaire Elon Musk, aimed at reducing the federal workforce. A Reversal of Two Decades of Progress Lead researcher Dr. Davide Rasella, from the Barcelona Institute for Global Health, said the funding cuts threaten to “abruptly halt — and even reverse — two decades of progress in health among vulnerable populations.” “For many low- and middle-income countries, the resulting shock would be comparable in scale to a global pandemic or a major armed conflict,” Rasella added. Using historical data from 133 nations, the research team found that USAID programmes had prevented approximately 91 million deaths between 2001 and 2021. Their model now forecasts 14 million avoidable deaths by 2030 if the 83% funding cut remains in place, with around 700,000 children under five expected to die every year as a result. Global Alarm and Humanitarian Crisis The report was released just as dozens of world leaders convened in Seville, Spain for the largest United Nations-led aid conference in a decade. The urgency of the moment was underscored by recent developments: USAID’s Legacy and Political Shift The United States remains the world’s largest humanitarian aid provider, operating in more than 60 countries, primarily through contractors. However, the Trump administration has redirected many USAID functions to the State Department, with Rubio stating that 1,000 remaining programmes will now be managed “more effectively” in consultation with Congress. The White House has also accused USAID of supporting liberal-leaning projects, a rationale that has drawn criticism from international observers and humanitarian organizations. The Road Ahead Experts warn that without urgent course correction or global cooperation to fill the funding gap, millions of lives are at risk, particularly in fragile regions already suffering from food insecurity, lack of healthcare access, and climate-related crises. As debates continue in Seville, the Lancet report stands as a sobering call for action, urging nations to step up their commitments before the consequences become irreversible.

Recbio Signs Licensing Deal with Biological E for 9-Valent HPV Vaccine REC603

Jiangsu Recbio Technology Co. Ltd, a leading biopharmaceutical company from China, has signed a licensing and technology transfer agreement with Hyderabad-based Biological E Limited (BE) for its Recombinant 9-valent HPV vaccine, REC603. The vaccine is designed to protect against nine strains of Human Papillomavirus (HPV), including those that cause cervical, vulvar, vaginal, anal, oropharyngeal cancers, and genital warts. 🧬 What the Deal Involves Under the agreement: 🏭 Manufacturing and Global Goals The local production of REC603 by BE is aimed at meeting the rising global demand for cervical cancer prevention. According to the companies, large-scale manufacturing will begin once the technology transfer is fully complete. 🗣️ Company Statements Dr Liu Yong, Chairman and CEO of Recbio, hailed the partnership as a “major milestone in the global expansion” of their vaccine pipeline.Mahima Datla, Managing Director of Biological E, said the deal reflects their ongoing commitment to making life-saving vaccines more affordable and accessible, especially in low- and middle-income countries. This collaboration is expected to significantly boost India’s HPV immunisation efforts, while also expanding the global availability of affordable vaccines in the fight against HPV-related cancers.

Recognizing Heart Attack Warning Signs a Month in Advance Can Save Lives

Cardiovascular diseases were responsible for 17.9 million deaths in 2019, with 85% caused by heart attacks and strokes. While heart attacks often seem sudden, studies show that early warning signs can appear days or even weeks beforehand. Identifying and responding to these signs can make the difference between life and death. Here are five warning symptoms of a heart attack that may appear up to a month before the event: 1. Chest Discomfort or Heaviness One of the most common and critical signs, chest pain doesn’t always present as sharp pain. Instead, many describe it as: This subtle discomfort could signal that the heart muscle is struggling to receive enough oxygen-rich blood. 2. Unusual or Persistent Fatigue Fatigue that’s unexplained and doesn’t improve with rest is a common early warning—especially among women. It may feel like: This could indicate that the heart is struggling to pump blood efficiently, leading to reduced oxygen delivery throughout the body. 3. Shortness of Breath If you suddenly feel winded during light activities or even at rest, don’t dismiss it: 4. Palpitations or Irregular Heartbeats A racing or irregular heartbeat can feel like: Palpitations may indicate that the heart is struggling to maintain normal rhythm under stress or reduced blood flow. 5. Sleep Disturbances Many people report changes in sleep patterns before a heart attack, such as: These signs may suggest the nervous system and heart are under stress, even at rest. 🩺 When to Seek Help Don’t delay. If you or a loved one experience any combination of these symptoms—especially chest discomfort, fatigue, or breathlessness—seek immediate medical attention. Time is critical in preventing a full-blown heart attack and improving survival chances. “Let’s wait and see” can be deadly. When in doubt, call emergency services immediately.

Noida Police Bust Fake Paneer Racket; 1,400 Kg Seized, Factory in Aligarh Raided

In a major breakthrough, Noida Police have uncovered a large-scale fake paneer (cottage cheese) racket operating from Aligarh and supplying counterfeit dairy products across Delhi-NCR. Acting on a tip-off, authorities seized 1,400 kilograms of fake paneer being transported to Noida in a pick-up truck and arrested the driver. Fake Paneer at ₹180–₹220 per Kg According to reports, the racket had been active for nearly six months, supplying fake paneer at ₹180–₹220 per kg, far cheaper than genuine paneer. The adulterated product was distributed widely to vendors, roadside eateries, and small food outlets across the National Capital Region. Noida Interception Leads to Aligarh Factory The operation began when Noida Sector-63 Police stopped a suspicious vehicle and discovered the massive consignment of fake paneer. The driver, 32-year-old Gulfam, was taken into custody and during interrogation revealed that the source of the paneer was a factory in Sahajpura village, Aligarh. Raid Reveals Fake Dairy Manufacturing Setup Following the lead, police conducted a raid on the Aligarh-based plant and arrested three individuals: At the site, police found significant quantities of raw materials and equipment used in making the fake paneer, including: How the Fake Paneer Was Made During questioning, the accused described the manufacturing process: Investigation Ongoing Apart from the 1,400 kg of fake paneer, all raw materials and machinery used in production were seized. Police are now tracking the buyers and distribution network, including vendors and establishments that have been selling or using this hazardous counterfeit product. The bust raises serious concerns about food safety and public health, especially in light of the widespread distribution of these adulterated dairy products. Authorities have urged citizens to be cautious and report suspicious paneer quality to food safety officers.

Torrent Pharma to Acquire Controlling Stake in JB Chemicals in ₹18,000 Cr Deal, Becomes Second Largest Indian Pharma Player

In a landmark move set to reshape India’s pharmaceutical landscape, Torrent Pharmaceuticals has announced the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals (JB Chem) in a deal valued at approximately ₹18,000 crore, including an open offer. This becomes the second-largest deal in the Indian pharma sector, only behind Sun Pharma’s $4 billion (₹24,000 crore) acquisition of Ranbaxy over a decade ago. Key Highlights of the Deal: Once completed, this acquisition will make Torrent Pharma the second most valued pharma company in India after Sun Pharma, with combined revenues exceeding ₹15,000 crore, placing it firmly among the top five pharmaceutical players in the country. Future Merger and Share Swap Plan: In the second phase, Torrent Pharma and JB Chem will be merged under a scheme of arrangement, wherein: Background and Strategic Rationale: Regulatory Approval: The transaction and merger scheme are subject to necessary regulatory and statutory approvals. With this acquisition, Torrent Pharma significantly boosts its product portfolio, distribution strength, and global reach—solidifying its position as a formidable force in the Indian and international pharmaceutical markets.

Switch Language »